Q&A with Bladder Cancer Specialist

Dr. Matthew Galsky, Director of GU Medical Oncology, The Tisch Cancer Institute, Mount Sinai, New York discusses clinical trial data and RWE in assessing treatment options for patients with high-risk urothelial carcinoma. Click here to listen to the podcast.